Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Research

Is human herpesvirus 8 infection more common in men than in women? an updated meta-analysis

verfasst von: Haibo Gong, Shuai Zhang, Jinfa Dou, Jing Chen

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

Abstract

Background

Clinically, most patients with Kaposi's sarcoma (KS) are male, and several direct and indirect mechanisms may underlie this increased susceptibility in men, Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is considered to be the primary etiological agent responsible for KS. Thus, we propose the hypothesis that men are more susceptible to HHV-8 infection, leading to a higher incidence of Kaposi's sarcoma among males. A meta-analysis was conducted to evaluate the association between gender and HHV-8 seropositivity in the general population.

Methods

A comprehensive literature search was performed using 6 online databases: PubMed, EMBASE, Cochrane library, Web of Science, CNKI, and Wanfang. Studies published before March 15, 2023, were included.

Results

In all, 33 articles including 41 studies were included in the meta-analysis. In the included adult population. men had a higher risk of HHV-8 infection than did women in adult populations from all over the world (odds ratio [OR]: 1.08, 95% confidence interval [CI]: 1.01–1.15), but no differences were found in child population from all over the world (OR: 0.90, 95% CI: 0.79–1.01). There was a significant difference in HHV-8 seroprevalence between men and women in sub-Saharan Africa (SSA) adult population (OR: 1.15, 95% CI: 1.05–1.26). However, no significant differences were observed in sub-Saharan Africa (SSA) child population (OR: 0.90, 95%CI 0.78–1.03). As for other continents, the results showed no significant difference, such as the Asian population (OR: 1.03, 95%CI: 0.92–1.16). or the European and American populations (OR 1.01, 95%CI 0.87–1.17).

Conclusion

There was a slight gender disparity for HHV-8 infection in the adult population. Among the adult populations from SSA and globally, men were more likely to be infected with HHV-8 than were women. However, no statistical significance was observed in the child populations from SSA and globally. In the future, the inclusion of more standardized studies may strengthen the results of this study.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12879-024-09346-5.
This work was presented at the 25th International Conference on KSHV and Related Agents; June 19 – June 23, 2023; Dar es Salaam, Tanzania.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
KS
Kaposi's sarcoma
PEL
Primary effusion lymphoma
SSA
Sub-Saharan African

Background

Kaposi's sarcoma (KS) is a complex angioproliferative neoplasm that has attracted the attention of researchers and clinicians for decades [1, 2]. It primarily affects the skin of the extremities, face, trunk, external genitalia, and oropharyngeal mucosa. Lymph nodes and internal organs, most notably the respiratory and gastrointestinal tracts, are also often involved. It was first described and named by Moritz Kaposi, an Austro-Hungarian dermatologist, in 1872 [3]. It is unclear why patients with various types of KS are predominantly male. Several factors such as hormonal factors, inherent differences in the immune system, and high-risk behaviors may contribute to this phenomenon. Kaposi's sarcoma-associated herpes virus (KSHV), also known as human herpesvirus 8 (HHV-8) is considered a crucial factor in the pathogenesis of KS [4, 5]. Whether HHV-8 seroprevalence differs between men and women and thus explains the male predominance of KS, is yet to be determined.
HHV-8 is the primary cause of several malignancies, including KS, primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD) [4]. Understanding the seroprevalence of HHV-8 is essential for assessing the burden of this virus and developing strategies to prevent the associated diseases.
Begré et al. [6] conducted a meta-analysis on this in 2016 and concluded that there was a slight gender disparity in the incidence of KS in sub-Saharan Africa (SSA). However, their findings may be outdated, since more relevant original articles on this issue have been published, we believe that the conclusion may be different now. In this meta-analysis, we not only included more English articles, but also included studies from the Asian continent in Chinese databases. Subgroup analyses were conducted separately in populations from different continents. Therefore, it is necessary to provide a more comprehensive evaluation of this issue. We conducted an updated meta-analysis to comprehensively evaluate the association between gender and HHV-8 seropositivity.

Methods

Search strategy

We searched the main English and Chinese language databases. Two of our researchers (Hai-bo Gong and Shuai Zhang) conducted a literature search of the PubMed, EMBASE, Cochrane library, Web of Science, CNKI, and Wanfang databases for articles published before March 15, 2023. The electronic search strategy of PubMed was as follows: ((((((((((((("Herpesvirus 8, Human"[Mesh]) OR HHV-8) OR KSHV) OR Kaposi's Sarcoma-Associated Herpesvirus) OR Kaposi's Sarcoma Associated Herpesvirus) OR Sarcoma-Associated Herpesvirus, Kaposi) OR Herpesvirus, Kaposi's Sarcoma-Associated) OR Herpesvirus, Kaposi's Sarcoma Associated) OR Human Herpesvirus 8) OR Herpesvirus, Kaposi's Sarcoma-Associated) OR Kaposi's Sarcoma-Associated Herpesviruses) OR Sarcoma-Associated Herpesviruses, Kaposi's)) AND ((((((seroprevalence) OR "Seroepidemiologic Studies"[Mesh])) OR ((Epidemiology) OR "Epidemiology"[Mesh])) OR ((incidence) OR "Incidence"[Mesh])) OR ((Prevalence) OR "Prevalence"[Mesh])).

Inclusion and exclusion criteria

We collected data from cross-sectional studies on HHV-8 seroprevalence worldwide. The recruited participants in the included studies were representative of the general local population. The following information was extracted from the included studies: proportion of seropositive individuals by sex, race, and age. Therefore, studies conducted on blood donors, hospital-based studies, and studies conducted on specific populations, such as men who have sex with men, patients with solid organ transplants, HIV-positive individuals, those using intravenous (IV) drugs, or those who were incarcerated, were excluded.

Data extraction

Two researchers, Gong Haibo and Zhang Shuai, independently extracted all the information from the included literature, including the authors, year of publication, country and region, total number of participants, number of men, number of women, frequency of seropositivity, frequency of seronegativity, age composition of the participants (children or adults), and number of seropositive individuals. Methods for the detection of HHV-8 and antibodies used in the detection process were also recorded. In case of disagreement, the two authors discussed the issue and submitted it to a third author for adjudication.

Statistical analyses

This meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines [7]. Both the Q-statistical test and I2 test were used to calculate between-study heterogeneity [8, 9]. In general, random- and fixed-effects models were used to combine the data in the presence (p < 0.1, I2 > 40%) or absence of heterogeneity (p > 0.1, I2 < 40%). The results of I2 statistic and Q statistic are often inconsistent in the actual calculation process. Because the number of studies in different subgroup analysis varies greatly, I2 statistic results will not change with the change of the number of studies, when in this situation, we used the I2 statistic to determine whether the heterogeneity was significant. Stata version 12.0 (StataCorp LP, College Station, TX, USA) was used to generate the forest and Egger’s plots.

Results

Number of eligible, included, and excluded studies

Using our search strategy, we searched six different databases, including the four main English language databases, PubMed, EMBASE, Cochrane and the Web of Science, and the two main Chinese language databases, CNKI and Wanfang. We then eliminated duplicate studies, and further eliminated abstracts, case reports, reviews, and other irrelevant studies that were not related to the content of this issue. Ultimately, 33 articles were included, of which 28 were in English and 5 in Chinese [1042]. The literature identification process is illustrated in Fig. 1.

Characteristics of included studies

Forty-one study groups from 33 articles included 25,902 male and 28,052 female participants. Detailed information about each study is presented in Table 1. The studies were from five continents: 15 (45%) from Asia, 12 (36%) from Africa, 2 (6%) from North America, 1 (3%) from South America, and 3 (9%) from the Europe. Of these, 10 studies included only children and 20 studies included only adults. The ages of the participants in the remaining 11 studies were unspecified.
Table 1
Main characteristics of included studies
Author
Year
Country
Age
HHV-8 tested used
Sample size
HHV-8( +)
HHV-8(-)
Male
Female
 
Male
Female
Anderson
2008
USA
Children
EIA
4166
27
35
2026
2078
Antony
2021
Gabon
Adult
IFA
1020
229
143
403
245
Biryahwaho
2010
Uganda
Adult
EIA
2715
712
793
526
684
Butler (1)
2011
Uganda
Children
EIA
1382
189
183
504
506
Butler (2)
2011
Uganda
Adult
EIA
1477
298
294
396
489
Dedicoat
2004
South Africa
Children
EIA
2497
127
160
1136
1074
Engels
2007
USA
Adult
EIA
13,894
141
166
6159
7428
Fu
2009
China
Adult
EIA
2228
199
228
891
910
Fang Yuan
2022
China
unspecified
ELISA
678
48
60
219
351
Malope
2008
South Africa
Adult
EIA
1146
197
336
218
395
Mbulaiteye
2003
Tanzania
Children
EIA
361
125
122
88
102
Mbulaiteye
2008
Egypt
Adult
EIA
730
52
125
183
370
Angela Nalwoga
2020
Uganda
unspecified
ELISA
825
49
41
357
378
Perna (1)
2000
Italy
Children
IFA
319
9
11
159
140
Perna (2)
2000
Italy
Children
IFA
651
52
40
280
279
Plancoulaine (1)
2000
French Guiana
Children
IFA
656
23
25
329
279
Plancoulaine (2)
2000
French Guiana
Adult
IFA
681
58
71
251
301
Plancoulaine (1)
2004
Cameroon
Children
IFA
309
67
73
86
83
Plancoulaine (2)
2004
Cameroon
Adult
IFA
299
105
119
29
46
Serraino
2003
Italy
Adult
IFA
200
9
6
91
94
Tedeschi
2006
Sweden
Adult
IFA
516
39
36
218
223
Wang
2011
China
Adult
EIA
1008
111
122
386
389
Wawer
2001
Uganda
Adult
IFA
522
102
99
137
184
Wen
2021
China
unspecified
ELISA
1078
96
167
324
487
Zheng Jun (1)
2017
China
Adult
IFA
700
136
112
228
224
Zheng Jun (2)
2017
China
Adult
IFA
594
105
142
139
208
Zhang Tiejun
2017
China
Adult
IFA
1583
96
66
887
534
Cao Yifei
2014
China
Children
IFA
178
47
39
61
31
Angela Nalwoga (1)
2019
Uganda
unspecified
ELISA
1571
646
561
155
209
Angela Nalwoga (2)
2019
Uganda
unspecified
ELISA
1310
641
450
103
116
Kay L. Crabtree
2017
Zambia
Children
IFA
270
65
72
76
57
Ryoko Awazawa
2017
Japan
Adult
ELISA
1132
97
77
489
469
Yuan Huangbo
2018
China
Adult
IFA
594
105
142
139
208
Zhang xin
2022
China
Adult
IFA
721
68
106
208
339
Zhang ying (1)
2013
China
unspecified
ELISA
1008
22
21
529
436
Zhang ying (2)
2013
China
unspecified
ELISA
100
20
20
402
527
Zhang ying (3)
2013
China
unspecified
ELISA
882
28
21
472
361
Fang yuan
2017
China
unspecified
ELISA
1000
87
103
293
517
Fang qin
2006
China
unspecified
ELISA
560
18
11
299
232
Zhu ye
2010
China
unspecified
ELISA
1281
38
55
643
545
He miao
2014
China
Adult
IFA
171
58
29
42
42
EIA Enzyme immunoassay, IFA Immunofluorescence assay, ELISA Enzyme linked immunosorbent assay

Meta-analysis results

For the total included population from all over the world, random-effects models analyses showed no significant difference between gender and HHV-8 seropositivity (OR: 1.07, 95% CI: 0.99–1.15; Fig. 2), while the fixed-effects models showed that there was a significant association between gender and HHV-8 seropositivity (OR: 1.07, 95% CI: 1.02–1.13; Appendix.1). Because of some degree of heterogeneity between studies (I2 = 44.8%, p = 0.001), we finally selected the random-effects model results as the final calculation. For the total included adult population, there was a significant association between male gender and HHV-8 seropositivity (OR: 1.08, 95% CI: 1.01–1.15; Fig. 3a); however, no such association was found in the child population (OR: 0.90, 95% CI: 0.79–1.01; Fig. 3b).
In the SSA region, For the total population (I2 = 58.2%, p = 0.002), the heterogeneity between studies was large enough so that we choose the random effect model for calculation. The results showed no significant difference (OR: 1.11, 95% CI: 0.99–1.25, Fig. 4). While using a fixed-effect model, it was found that male gender was associated with HHV-8 seropositivity in the total population (OR 1.13, 95% CI 1.05–1.21; Appendix.2). In the adult population subgroup (OR: 1.15, 95% CI: 1.05–1.26; Fig. 5a), but not in children (OR: 0.90, 95% CI: 0.78–1.03; Fig. 5b).
For other continents in the world, the results also showed that no statistically significant difference was observed (Asian region, OR: 1.03, 95% CI: 0.92–1.16; Fig. 6a; European and American population, OR: 1.01, 95%CI: 0.87–1.17; Fig. 6b).

Sensitivity analysis and study bias

We removed the included studies individually to test the robustness and reliability of the results. The significance of the pooled ORs and 95% CIs did not change, indicating the stability of the results.
We used Egger's test to calculate the publication bias of the included studies in each subgroup analysis, and these results are shown in Figs. 7, 8, and 9. All the p-values of Egger’s test were > 0.1, indicating that there was no publication bias between the included studies in all group analyses. Including the total population from all over the world (p = 0.504, Fig. 7a); adult-only population from all over the world (p = 0.455, Fig. 7b); child-only population from all over the world (p = 0.489, Fig. 7c); total SSA population (p = 0.477, Fig. 8a); adult-only population from SSA (p = 0.939, Fig. 8b); child-only population from SSA (p = 0.730, Fig. 8c); Asian population (p = 0.531, Fig. 9a); and European and American population (p = 0.774, Fig. 9b).

Discussion

This is an updated meta-analysis based on the work of Begré et al. [6]. To date, this meta-analysis is the most comprehensive. Our results suggested that HHV-8 infection is slightly more common in men than in women among the adult SSA population as well as the adult population from all over the world. However, in children across all populations, not just SSA, there were no results suggesting that boys were more likely to be infected with HHV-8 than girls. These results suggest that the male gender vulnerability of HHV-8 infection may not be related to genetic background, but to living habits and environmental factors in the region. The importance of the results from the fixed-effects model analysis of all included populations in SSA and all over the world should not be overlooked; we believe that when the quality of research is sufficiently standardized and the number of quantity researchers is large enough, we can apply the fixed-effects model and may conclude that there is a statistical difference.
The higher incidence of KS in men than in women may be attributed to a combination of immune system differences; hormonal, viral and genetic factors; and high-risk behaviors. Understanding these factors is crucial to developing better strategies for the prevention, early detection, and treatment of KS. The sero-epidemiologic distribution of HHV-8 may play a role in the pathogenesis of KS. It is probably not a coincidence that the results for the SSA adult population were consistent with those for all included adult population worldwide. However, this remains unclear because, clinically, far more male cases than female cases of KS have been encountered. Yet our results showed that men have only a weak predisposition to HHV-8 infection compared with women, since none of the ORs were very large. The statistical differences observed in our study were only slightly significant. Therefore, the higher number of men affected by KS compared to women is likely multifactorial, involving a combination of biological, behavioral, and social factors. The extent to which infection with the Kaposi's sarcoma-associated herpesvirus contributes to this phenomenon requires further research. There may be additional patterns underlying these results that remain to be understood.
This study has several limitations. Firstly, the male gender predominance in KS may have multifactorial causes. This study only examines this issue from the perspective of HHV-8 infection. Other contributing factors could include variances in immune system responses between men and women, hormonal influences, genetic predispositions, and gender-related behaviors. However, their exact impacts and roles remain unclear. Secondly, this study only included papers published in English and Chinese, excluding those published in other languages, which may introduce selection bias. Moreover, variations in technical methods, reagent manufacturers, age determination criteria for children in subgroup analyses, and the stringency of study population screening across different investigations could also introduce biases, thereby affecting the final outcomes. Thirdly, while we aimed to include all relevant studies on the global seroprevalence of HHV-8, the number of studies included was relatively limited. Further research with larger sample sizes and more comprehensive analyses is warranted.

Conclusion

Adult populations from Sub-Saharan Africa (SSA), similar to adult populations worldwide, are more likely to test positive for HHV-8 seropositivity than women. However, no significant differences were observed among children from the same regions. These sero-epidemiological patterns of KSHV may help explain the higher prevalence of Kaposi's Sarcoma (KS) in men compared to women.

Declarations

All analyses in this study relied on previously published literature and public databases, and no human participants were included. Therefore, this study did not require ethical approval or patient consent.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Sternbach G, Varon J. Moritz Kaposi: idiopathic pigmented sarcoma of the skin. J Emerg Med. 1995;13:671–4.CrossRefPubMed Sternbach G, Varon J. Moritz Kaposi: idiopathic pigmented sarcoma of the skin. J Emerg Med. 1995;13:671–4.CrossRefPubMed
4.
Zurück zum Zitat Lange P, Damania B. Kaposi's Sarcoma-Associated Herpesvirus (KSHV). Trends Microbiol. 2020;28:236–7.CrossRefPubMed Lange P, Damania B. Kaposi's Sarcoma-Associated Herpesvirus (KSHV). Trends Microbiol. 2020;28:236–7.CrossRefPubMed
5.
Zurück zum Zitat Barrett L, Dai L, Wang S, Qin Z. Kaposi’s sarcoma-associated herpesvirus and extracellular vesicles. J Med virol. 2021;93:3294–9.CrossRefPubMed Barrett L, Dai L, Wang S, Qin Z. Kaposi’s sarcoma-associated herpesvirus and extracellular vesicles. J Med virol. 2021;93:3294–9.CrossRefPubMed
6.
Zurück zum Zitat Begré L, Rohner E, Mbulaiteye SM, Egger M, Bohlius J. Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis. Int J Cancer. 2016;139:776–83.CrossRefPubMedPubMedCentral Begré L, Rohner E, Mbulaiteye SM, Egger M, Bohlius J. Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis. Int J Cancer. 2016;139:776–83.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med. 2009;6:e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med. 2009;6:e1000097.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMed
9.
Zurück zum Zitat Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
10.
Zurück zum Zitat Anderson LA, Li Y, Graubard BI, Whitby D, Mbisa G, Tan S, Goedert JJ, Engels EA. Human herpesvirus 8 seroprevalence among children and adolescents in the United States. Pediatr Infect Dis J. 2008;27:661–4.CrossRefPubMed Anderson LA, Li Y, Graubard BI, Whitby D, Mbisa G, Tan S, Goedert JJ, Engels EA. Human herpesvirus 8 seroprevalence among children and adolescents in the United States. Pediatr Infect Dis J. 2008;27:661–4.CrossRefPubMed
11.
Zurück zum Zitat Biryahwaho B, Dollard SC, Pfeiffer RM, Shebl FM, Munuo S, Amin MM, Hladik W, Parsons R, Mbulaiteye SM. Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population-based sample in Uganda. J Infect Dis. 2010;202:1347–53.CrossRefPubMed Biryahwaho B, Dollard SC, Pfeiffer RM, Shebl FM, Munuo S, Amin MM, Hladik W, Parsons R, Mbulaiteye SM. Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population-based sample in Uganda. J Infect Dis. 2010;202:1347–53.CrossRefPubMed
12.
Zurück zum Zitat Butler LM, Were WA, Balinandi S, Downing R, Dollard S, Neilands TB, Gupta S, Rutherford GW, Mermin J. Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis. 2011;203:625–34.CrossRefPubMedPubMedCentral Butler LM, Were WA, Balinandi S, Downing R, Dollard S, Neilands TB, Gupta S, Rutherford GW, Mermin J. Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis. 2011;203:625–34.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, Whitby D, Schulz TF. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis. 2004;190:1068–75.CrossRefPubMed Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, Whitby D, Schulz TF. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis. 2004;190:1068–75.CrossRefPubMed
14.
Zurück zum Zitat Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis. 2007;196:199–207.CrossRefPubMed Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis. 2007;196:199–207.CrossRefPubMed
15.
Zurück zum Zitat Fu B, Sun F, Li B, Yang L, Zeng Y, Sun X, Xu F, Rayner S, Guadalupe M, Gao SJ, Wang L. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus and risk factors in Xinjiang. China J Med Virol. 2009;81:1422–31.CrossRefPubMed Fu B, Sun F, Li B, Yang L, Zeng Y, Sun X, Xu F, Rayner S, Guadalupe M, Gao SJ, Wang L. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus and risk factors in Xinjiang. China J Med Virol. 2009;81:1422–31.CrossRefPubMed
16.
Zurück zum Zitat Malope BI, MacPhail P, Mbisa G, MacPhail C, Stein L, Ratshikhopha EM, Ndhlovu L, Sitas F, Whitby D. No evidence of sexual transmission of Kaposi’s sarcoma herpes virus in a heterosexual South African population. AIDS (London, England). 2008;22:519–26.CrossRefPubMed Malope BI, MacPhail P, Mbisa G, MacPhail C, Stein L, Ratshikhopha EM, Ndhlovu L, Sitas F, Whitby D. No evidence of sexual transmission of Kaposi’s sarcoma herpes virus in a heterosexual South African population. AIDS (London, England). 2008;22:519–26.CrossRefPubMed
17.
Zurück zum Zitat Mbulaiteye SM, Pfeiffer RM, Dolan B, Tsang VC, Noh J, Mikhail NN, Abdel-Hamid M, Hashem M, Whitby D, Thomas Strickland G, Goedert JJ. Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis. 2008;14:586–91.CrossRefPubMedPubMedCentral Mbulaiteye SM, Pfeiffer RM, Dolan B, Tsang VC, Noh J, Mikhail NN, Abdel-Hamid M, Hashem M, Whitby D, Thomas Strickland G, Goedert JJ. Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis. 2008;14:586–91.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis. 2003;187:1780–5.CrossRefPubMed Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis. 2003;187:1780–5.CrossRefPubMed
19.
Zurück zum Zitat Perna AM, Bonura F, Vitale F, Viviano E, Di Benedetto MA, Ajello F, Villafrate MR, Prestileo T, Mancuso S, Goedert JJ, Romano N. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol. 2000;29:175–9.CrossRefPubMed Perna AM, Bonura F, Vitale F, Viviano E, Di Benedetto MA, Ajello F, Villafrate MR, Prestileo T, Mancuso S, Goedert JJ, Romano N. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol. 2000;29:175–9.CrossRefPubMed
20.
Zurück zum Zitat Plancoulaine S, Abel L, Trégouët D, Duprez R, van Beveren M, Tortevoye P, Froment A, Gessain A. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res. 2004;64:8782–7.CrossRefPubMed Plancoulaine S, Abel L, Trégouët D, Duprez R, van Beveren M, Tortevoye P, Froment A, Gessain A. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res. 2004;64:8782–7.CrossRefPubMed
21.
Zurück zum Zitat Plancoulaine S, Abel L, van Beveren M, Trégouët DA, Joubert M, Tortevoye P, de Thé G, Gessain A. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet (London, England). 2000;356:1062–5.CrossRefPubMed Plancoulaine S, Abel L, van Beveren M, Trégouët DA, Joubert M, Tortevoye P, de Thé G, Gessain A. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet (London, England). 2000;356:1062–5.CrossRefPubMed
22.
Zurück zum Zitat Serraino D, Corona RM, Giuliani M, Farchi F, Sarmati L, Uccella I, Andreoni M, Rezza G. Infection with human herpesvirus type 8 and kaposi’s sarcoma in a central Italian area formerly endemic for malaria. Infection. 2003;31:47–50.CrossRefPubMed Serraino D, Corona RM, Giuliani M, Farchi F, Sarmati L, Uccella I, Andreoni M, Rezza G. Infection with human herpesvirus type 8 and kaposi’s sarcoma in a central Italian area formerly endemic for malaria. Infection. 2003;31:47–50.CrossRefPubMed
23.
Zurück zum Zitat Tedeschi R, Bidoli E, Agren A, Hallmans G, Wadell G, De Paoli P, Dillner J. Epidemiology of Kaposi’s Sarcoma herpesvirus (HHV8) in Västerbotten County. Sweden J Med Virol. 2006;78:372–8.CrossRefPubMed Tedeschi R, Bidoli E, Agren A, Hallmans G, Wadell G, De Paoli P, Dillner J. Epidemiology of Kaposi’s Sarcoma herpesvirus (HHV8) in Västerbotten County. Sweden J Med Virol. 2006;78:372–8.CrossRefPubMed
24.
Zurück zum Zitat Wang H, Liu J, Dilimulati, Li L, Ren Z, Wen H, Wang X. Seroprevalence and risk factors of Kaposi’s sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China. Virol J. 2011;8:539.CrossRefPubMedPubMedCentral Wang H, Liu J, Dilimulati, Li L, Ren Z, Wen H, Wang X. Seroprevalence and risk factors of Kaposi’s sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China. Virol J. 2011;8:539.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Wawer MJ, Eng SM, Serwadda D, Sewankambo NK, Kiwanuka N, Li C, Gray RH. Prevalence of Kaposi's sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District. Uganda Sex Transm Dis. 2001;28:77–81.CrossRefPubMed Wawer MJ, Eng SM, Serwadda D, Sewankambo NK, Kiwanuka N, Li C, Gray RH. Prevalence of Kaposi's sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District. Uganda Sex Transm Dis. 2001;28:77–81.CrossRefPubMed
26.
Zurück zum Zitat Zheng J, Yang Y, Cui M, Shu ZJ, Han LL, Liu ZQ, Wood C, Zhang T, Zeng Y. Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang. China Virol Sin. 2017;32:396–403.CrossRefPubMed Zheng J, Yang Y, Cui M, Shu ZJ, Han LL, Liu ZQ, Wood C, Zhang T, Zeng Y. Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang. China Virol Sin. 2017;32:396–403.CrossRefPubMed
27.
Zurück zum Zitat Zhang T, Liu Z, Wang J, Minhas V, Wood C, Clifford GM, He N, Franceschi S. Seroprevalence of antibodies against Kaposi’s sarcoma-associated herpesvirus among HIV-negative people in China. Infect Agent Cancer. 2017;12:32.CrossRefPubMedPubMedCentral Zhang T, Liu Z, Wang J, Minhas V, Wood C, Clifford GM, He N, Franceschi S. Seroprevalence of antibodies against Kaposi’s sarcoma-associated herpesvirus among HIV-negative people in China. Infect Agent Cancer. 2017;12:32.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Cao Y, Minhas V, Tan X, Huang J, Wang B, Zhu M, Gao Y, Zhao T, Yang L, Wood C. High prevalence of early childhood infection by Kaposi’s sarcoma-associated herpesvirus in a minority population in China. Clin Microbiol Infect. 2014;20:475–81.CrossRefPubMed Cao Y, Minhas V, Tan X, Huang J, Wang B, Zhu M, Gao Y, Zhao T, Yang L, Wood C. High prevalence of early childhood infection by Kaposi’s sarcoma-associated herpesvirus in a minority population in China. Clin Microbiol Infect. 2014;20:475–81.CrossRefPubMed
29.
Zurück zum Zitat Nalwoga A, Webb EL, Chihota B, Miley W, Walusimbi B, Nassuuna J, Sanya RE, Nkurunungi G, Labo N, Elliott AM, Cose S, Whitby D, et al. Kaposi’s sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands. PLoS Negl Trop Dis. 2019;13:e0007776.CrossRefPubMedPubMedCentral Nalwoga A, Webb EL, Chihota B, Miley W, Walusimbi B, Nassuuna J, Sanya RE, Nkurunungi G, Labo N, Elliott AM, Cose S, Whitby D, et al. Kaposi’s sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands. PLoS Negl Trop Dis. 2019;13:e0007776.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Crabtree KL, Wojcicki JM, Minhas V, Kankasa C, Mitchell C, Wood C. Association of Household Food- and Drink-Sharing Practices With Human Herpesvirus 8 Seroconversion in a Cohort of Zambian Children. J Infect Dis. 2017;216:842–9.CrossRefPubMedPubMedCentral Crabtree KL, Wojcicki JM, Minhas V, Kankasa C, Mitchell C, Wood C. Association of Household Food- and Drink-Sharing Practices With Human Herpesvirus 8 Seroconversion in a Cohort of Zambian Children. J Infect Dis. 2017;216:842–9.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Awazawa R, Utsumi D, Katano H, Awazawa T, Miyagi T, Hayashi K, Matori S, Uezato H, Takahashi K. High Prevalence of Distinct Human Herpesvirus 8 Contributes to the High Incidence of Non-acquired Immune Deficiency Syndrome-Associated Kaposi’s Sarcoma in Isolated Japanese Islands. J Infect Dis. 2017;216:850–8.CrossRefPubMed Awazawa R, Utsumi D, Katano H, Awazawa T, Miyagi T, Hayashi K, Matori S, Uezato H, Takahashi K. High Prevalence of Distinct Human Herpesvirus 8 Contributes to the High Incidence of Non-acquired Immune Deficiency Syndrome-Associated Kaposi’s Sarcoma in Isolated Japanese Islands. J Infect Dis. 2017;216:850–8.CrossRefPubMed
32.
Zurück zum Zitat Yuan H, Liu Z, Wu X, Fang Q, Zheng J, Zeng Y, Zhang T. Social behavioral correlates of Kaposi's sarcoma-associated herpesvirus infection among Han and Uygur populations in Xinjiang. China J Med Virol. 2019;91:457–62.CrossRefPubMed Yuan H, Liu Z, Wu X, Fang Q, Zheng J, Zeng Y, Zhang T. Social behavioral correlates of Kaposi's sarcoma-associated herpesvirus infection among Han and Uygur populations in Xinjiang. China J Med Virol. 2019;91:457–62.CrossRefPubMed
33.
Zurück zum Zitat Zhang X, Fang Q, Zhu S, Wu X, Yuan H, Liu Z, Xu Y, Chen T, Zeng Y, Zhang T. Environmental risk factors and genetic markers of Kaposi’s sarcoma-associated herpesvirus infection among Uygur population in Xinjiang. China J Med Virol. 2022;94:2755–65.CrossRefPubMed Zhang X, Fang Q, Zhu S, Wu X, Yuan H, Liu Z, Xu Y, Chen T, Zeng Y, Zhang T. Environmental risk factors and genetic markers of Kaposi’s sarcoma-associated herpesvirus infection among Uygur population in Xinjiang. China J Med Virol. 2022;94:2755–65.CrossRefPubMed
34.
Zurück zum Zitat Fang Y, Li W, Zhang Y, Zhou C, Wu H, Zhang Y, Dai T, Wang J, Wang L, Chen T, Zhu Y, Wang L. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus and risk factors in Jiuquan area. China J Med Virol. 2022;94:6016–22.CrossRefPubMed Fang Y, Li W, Zhang Y, Zhou C, Wu H, Zhang Y, Dai T, Wang J, Wang L, Chen T, Zhu Y, Wang L. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus and risk factors in Jiuquan area. China J Med Virol. 2022;94:6016–22.CrossRefPubMed
35.
Zurück zum Zitat Mamimandjiami AI, Mouinga-Ondémé A, Ramassamy JL, Djuicy DD, Afonso PV, Mahé A, Lekana-Douki JB, Cassar O, Gessain A. Epidemiology and Genetic Variability of HHV-8/KSHV among Rural Populations and Kaposi's Sarcoma Patients in Gabon, Central Africa. Review of the Geographical Distribution of HHV-8 K1 Genotypes in Africa. Viruses 2021;13. Mamimandjiami AI, Mouinga-Ondémé A, Ramassamy JL, Djuicy DD, Afonso PV, Mahé A, Lekana-Douki JB, Cassar O, Gessain A. Epidemiology and Genetic Variability of HHV-8/KSHV among Rural Populations and Kaposi's Sarcoma Patients in Gabon, Central Africa. Review of the Geographical Distribution of HHV-8 K1 Genotypes in Africa. Viruses 2021;13.
36.
Zurück zum Zitat Nalwoga A, Nakibuule M, Marshall V, Miley W, Labo N, Cose S, Whitby D, Newton R. Risk Factors for Kaposi’s Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda. Clin Infect Dis. 2020;71:1055–62.CrossRefPubMed Nalwoga A, Nakibuule M, Marshall V, Miley W, Labo N, Cose S, Whitby D, Newton R. Risk Factors for Kaposi’s Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda. Clin Infect Dis. 2020;71:1055–62.CrossRefPubMed
37.
Zurück zum Zitat Wen Z, Li W, Fang Y, Zhou C, Lin K, Wu H, Zhang Y, Zhu Y, Xu X, Zeng Y, Lu B, Wang L. Prevalence and Risk Factors of Kaposi’s Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China. Can J Infect Dis Med Microbiol. 2021;2021:2555865.CrossRefPubMedPubMedCentral Wen Z, Li W, Fang Y, Zhou C, Lin K, Wu H, Zhang Y, Zhu Y, Xu X, Zeng Y, Lu B, Wang L. Prevalence and Risk Factors of Kaposi’s Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China. Can J Infect Dis Med Microbiol. 2021;2021:2555865.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Zhang Y. Epidemiological study of Kaposi's sarcoma-associated herpesviruses in Anhui province [D]. Anhui Medical University,2013. Zhang Y. Epidemiological study of Kaposi's sarcoma-associated herpesviruses in Anhui province [D]. Anhui Medical University,2013.
39.
Zurück zum Zitat Fang Yuan, Xu Changqing, Zhou Chang, et al. Serological analysis of Kapossarcoma-associated herpesvirus infection in general population in Dunhuang, Gansu Province. J Anhui Med University 2017 (5) : 697-700. Fang Yuan, Xu Changqing, Zhou Chang, et al. Serological analysis of Kapossarcoma-associated herpesvirus infection in general population in Dunhuang, Gansu Province. J Anhui Med University 2017 (5) : 697-700.
40.
Zurück zum Zitat Fang Q, Liu J, Bai ZQ, et al. Serological analysis of Kaposi’s sarcoma-associated herpesvirus infection in general population in Hubei province. Virologica Sinica. 2006;02:97–101. Fang Q, Liu J, Bai ZQ, et al. Serological analysis of Kaposi’s sarcoma-associated herpesvirus infection in general population in Hubei province. Virologica Sinica. 2006;02:97–101.
41.
Zurück zum Zitat Ye Z, Wang Linding Fu, Bishi. Serological survey of Kaposi’s sarcoma-associated herpesvirus infection in general population in Jingzhou, Hubei Province. J Mathematical Science and Medicine. 2010;23(03):328–30. Ye Z, Wang Linding Fu, Bishi. Serological survey of Kaposi’s sarcoma-associated herpesvirus infection in general population in Jingzhou, Hubei Province. J Mathematical Science and Medicine. 2010;23(03):328–30.
42.
Zurück zum Zitat He M. The prevalence and risk factors of KSHV infection in children in Xinjiang. Shihezi University, 2014. He M. The prevalence and risk factors of KSHV infection in children in Xinjiang. Shihezi University, 2014.
Metadaten
Titel
Is human herpesvirus 8 infection more common in men than in women? an updated meta-analysis
verfasst von
Haibo Gong
Shuai Zhang
Jinfa Dou
Jing Chen
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09346-5

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.